Strella Biotechnology, Inc. funding

Strella Biotechnology, Inc., a biotechnology company based in Seattle, WA, filed a Form D with the SEC on August 14, 2026 and reported $1.8M raised of a $3.3M offering.

Amount raised$1.8M

Offering size$3.3M

Filed with the SECAugust 14, 2026

First saleJune 29, 2026

IndustryBiotechnology

SecuritiesEquity, Options or warrants

LocationSeattle, WA

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far35

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Aug 14

Other health care rounds in Washington

Key Proteo, Inc.$2.3M · Oct 23Biotechnology Hexamer Therapeutics, Inc$500K · Sep 15Biotechnology Ora Biomedical, Inc.$205K · Nov 13Biotechnology Seattle Neurosound Solutions, Inc.$100K · Sep 22Other Health Care Q-Immune, Inc.$25K · Sep 28Biotechnology